Literature DB >> 33503019

Urinary 8-iso PGF2α and 2,3-dinor-8-iso PGF2α can be indexes of colitis-associated colorectal cancer in mice.

Yusuke Miyazaki1, Tatsuro Nakamura1, Shinya Takenouchi1, Akane Hayashi1, Keisuke Omori1, Takahisa Murata1.   

Abstract

Early diagnosis of colorectal cancer is needed to reduce the mortal consequence by cancer. Lipid mediators play critical role in progression of colitis and colitis-associated colon cancer (CAC) and some of their metabolites are excreted in urine. Here, we attempted to find novel biomarkers in urinary lipid metabolite of a murine model of CAC. Mice were received single administration of azoxymethane (AOM) and repeated administration of dextran sulfate sodium (DSS). Lipid metabolites in their urine was measured by liquid chromatography mass spectrometry and their colon was collected to perform morphological study. AOM and DSS caused inflammation and tumor formation in mouse colon. Liquid chromatography mass spectrometry-based comprehensive analysis of lipid metabolites showed that cyclooxygenase-mediated arachidonic acid (AA) metabolites, prostaglandins, and reactive oxygen species (ROS)-mediated AA metabolites, isoprostanes, were predominantly increased in the urine of tumor-bearing mice. Among that, urinary prostaglandin (PG)E2 metabolite tetranor-PGEM and PGD2 metabolite tetranor-PGDM were significantly increased in both of urine collected at the acute phase of colitis and the carcinogenesis phase. On the other hand, two F2 isoprostanes (F2-IsoPs), 8-iso PGF2α and 2,3-dinor-8-iso PGF2α, were significantly increased only in the carcinogenesis phase. Morphological study showed that infiltrated monocytes into tumor mass strongly expressed ROS generator NADPH (p22phox). These observations suggest that urinary 8-iso PGF2α and 2,3-dinor-8-iso PGF2α can be indexes of CAC.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33503019      PMCID: PMC7840041          DOI: 10.1371/journal.pone.0245292

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  39 in total

1.  Urine PGE-M: A metabolite of prostaglandin E2 as a potential biomarker of advanced colorectal neoplasia.

Authors:  J Chad Johnson; Carl R Schmidt; Martha J Shrubsole; D Dean Billheimer; Prashant R Joshi; Jason D Morrow; Martin J Heslin; M Kay Washington; Reid M Ness; Wei Zheng; David A Schwartz; Robert J Coffey; R Daniel Beauchamp; Nipun B Merchant
Journal:  Clin Gastroenterol Hepatol       Date:  2006-09-25       Impact factor: 11.382

Review 2.  NAD(P)H oxidase: role in cardiovascular biology and disease.

Authors:  K K Griendling; D Sorescu; M Ushio-Fukai
Journal:  Circ Res       Date:  2000-03-17       Impact factor: 17.367

3.  Inhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cells.

Authors:  Fabio Cianchi; Camillo Cortesini; Lucia Magnelli; Elena Fanti; Laura Papucci; Nicola Schiavone; Luca Messerini; Alfredo Vannacci; Sergio Capaccioli; Federico Perna; Matteo Lulli; Valentina Fabbroni; Giuliano Perigli; Paolo Bechi; Emanuela Masini
Journal:  Mol Cancer Ther       Date:  2006-11       Impact factor: 6.261

4.  Tetranor PGDM, an abundant urinary metabolite reflects biosynthesis of prostaglandin D2 in mice and humans.

Authors:  Wen-Liang Song; Miao Wang; Emanuela Ricciotti; Susanne Fries; Ying Yu; Tilo Grosser; Muredach Reilly; John A Lawson; Garret A FitzGerald
Journal:  J Biol Chem       Date:  2007-11-08       Impact factor: 5.157

5.  Increased levels of urinary PGE-M, a biomarker of inflammation, occur in association with obesity, aging, and lung metastases in patients with breast cancer.

Authors:  Patrick G Morris; Xi Kathy Zhou; Ginger L Milne; Daniel Goldstein; Laura C Hawks; Chau T Dang; Shanu Modi; Monica N Fornier; Clifford A Hudis; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2013-03-26

6.  Sialyl-Tn antigen as a marker of colon cancer risk in ulcerative colitis: relation to dysplasia and DNA aneuploidy.

Authors:  P Karlén; E Young; O Broström; R Löfberg; B Tribukait; K Ost; C Bodian; S Itzkowitz
Journal:  Gastroenterology       Date:  1998-12       Impact factor: 22.682

7.  Crucial involvement of tumor-associated neutrophils in the regulation of chronic colitis-associated carcinogenesis in mice.

Authors:  Kun Shang; Yu-Pan Bai; Chen Wang; Zhen Wang; Hong-Yu Gu; Xiang Du; Xiao-Yan Zhou; Chun-Lei Zheng; Ya-Yun Chi; Naofumi Mukaida; Ying-Yi Li
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

8.  The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies.

Authors:  Mariangela De Robertis; Emanuela Massi; Maria Luana Poeta; Simone Carotti; Sergio Morini; Loredana Cecchetelli; Emanuela Signori; Vito Michele Fazio
Journal:  J Carcinog       Date:  2011-03-24

9.  Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis.

Authors:  Hanyin Cheng; Lina Zhang; David E Cogdell; Hong Zheng; Aaron J Schetter; Matti Nykter; Curtis C Harris; Kexin Chen; Stanley R Hamilton; Wei Zhang
Journal:  PLoS One       Date:  2011-03-17       Impact factor: 3.240

10.  EP4 Receptor-Associated Protein in Macrophages Ameliorates Colitis and Colitis-Associated Tumorigenesis.

Authors:  Masato Nakatsuji; Manabu Minami; Hiroshi Seno; Mika Yasui; Hideyuki Komekado; Sei Higuchi; Risako Fujikawa; Yuki Nakanishi; Akihisa Fukuda; Kenji Kawada; Yoshiharu Sakai; Toru Kita; Peter Libby; Hiroki Ikeuchi; Masayuki Yokode; Tsutomu Chiba
Journal:  PLoS Genet       Date:  2015-10-06       Impact factor: 5.917

View more
  4 in total

1.  Prostanoid Signaling in Cancers: Expression and Regulation Patterns of Enzymes and Receptors.

Authors:  Pavel V Ershov; Evgeniy O Yablokov; Leonid A Kaluzhskiy; Yuri V Mezentsev; Alexis S Ivanov
Journal:  Biology (Basel)       Date:  2022-04-13

Review 2.  Therapeutic Influence on Important Targets Associated with Chronic Inflammation and Oxidative Stress in Cancer Treatment.

Authors:  Margarita Neganova; Junqi Liu; Yulia Aleksandrova; Sergey Klochkov; Ruitai Fan
Journal:  Cancers (Basel)       Date:  2021-12-01       Impact factor: 6.639

3.  The urinary lipid profile in cats with idiopathic cystitis.

Authors:  Shinya Takenouchi; Yui Kobayashi; Tatsuya Shinozaki; Koji Kobayashi; Tatsuro Nakamura; Tomohiro Yonezawa; Takahisa Murata
Journal:  J Vet Med Sci       Date:  2022-04-05       Impact factor: 1.105

Review 4.  Prostanoid Metabolites as Biomarkers in Human Disease.

Authors:  Helena Idborg; Sven-Christian Pawelzik
Journal:  Metabolites       Date:  2022-08-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.